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Abstract
Background: Oxidative stress is a key pathophysiological mechanism contributing to degenerative processes in
many neurodegenerative diseases and therefore, unraveling molecular mechanisms underlying various stages of
oxidative neuronal damage is critical to better understanding the diseases and developing new treatment
modalities. We previously showed that protein kinase C delta (PKCδ) proteolytic activation during the late stages of
oxidative stress is a key proapoptotic signaling mechanism that contributes to oxidative damage in Parkinson’s
disease (PD) models. The time course studies revealed that PKCδ activation precedes apoptotic cell death and that
cells resisted early insults of oxidative damage, suggesting that some intrinsic compensatory response protects
neurons from early oxidative insult. Therefore, the purpose of the present study was to characterize protective
signaling pathways in dopaminergic neurons during early stages of oxidative stress.
Results: Herein, we identify that protein kinase D1 (PKD1) functions as a key anti-apoptotic kinase to protect
neuronal cells against early stages of oxidative stress. Exposure of dopaminergic neuronal cells to H2O2 or 6-OHDA
induced PKD1 activation loop (PKD1S744/748) phosphorylation long before induction of neuronal cell death.
Blockade of PKCδ cleavage, PKCδ knockdown or overexpression of a cleavage-resistant PKCδ mutant effectively
attenuated PKD1 activation, indicating that PKCδ proteolytic activation regulates PKD1 phosphorylation.
Furthermore, the PKCδ catalytic fragment, but not the regulatory fragment, increased PKD1 activation, confirming
PKCδ activity modulates PKD1 activation. We also identified that phosphorylation of S916 at the C-terminal is a
preceding event required for PKD1 activation loop phosphorylation. Importantly, negative modulation of PKD1 by
the RNAi knockdown or overexpression of PKD1
S916A phospho-defective mutants augmented oxidative stress-
induced apoptosis, while positive modulation of PKD1 by the overexpression of full length PKD1 or constitutively
active PKD1 plasmids attenuated oxidative stress-induced apoptosis, suggesting an anti-apoptotic role for PKD1
during oxidative neuronal injury.
Conclusion: Collectively, our results demonstrate that PKCδ-dependent activation of PKD1 represents a novel
intrinsic protective response in counteracting early stage oxidative damage in neuronal cells. Our results suggest
that positive modulation of the PKD1-mediated compensatory protective mechanism against oxidative damage in
dopaminergic neurons may provide novel neuroprotective strategies for treatment of PD.
* Correspondence: akanthas@iastate.edu
Department of Biomedical Sciences, 2062 Veterinary Medicine Bldg, Iowa
State University, Ames, IA 50011, USA
Asaithambi et al. Molecular Neurodegeneration 2011, 6:43
http://www.molecularneurodegeneration.com/content/6/1/43
© 2011 Asaithambi et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.Background
Oxidative stress-induced neuronal damage has been
implicated in many neurodegenerative disorders including
Parkinson’s disease (PD), Alzheimer’s diseases, ALS,
Huntington’sd i s e a s e sa n ds t r o k e[ 1 - 7 ] .N e u r o n a lc e l l s
maintain an oxidant/antioxidant homeostatic balance,
and any breach in redox homeostasis causes excessive
ROS production, resulting in oxidative damage [8-10].
Oxidative stress triggers apoptosis through activation of
many signaling molecules including kinases and proteases
[11-15], and the roles of these signaling molecules in
dopaminergic cell death are being actively investigated.
Recently, we demonstrated that the proteolytic activation
of PKCδ, a novel PKC family member, mediates apoptosis
in cell culture and animal models of PD [15-19].
PKCδ can be activated by membrane translocation,
phosphorylation, or proteolytic cleavage by caspase-3,
leading to persistently active catalytic fragments. We
previously showed that various oxidative stressors like
H2O2,M P P
+ and 6-OHDA induce PKCδ cleavage to
increase the kinase activity and apoptosis in dopaminer-
gic cells [20,15,21,16]. The time course studies revealed
that the pro-apoptotic proteolytic activation of PKCδ
occurs well before apoptotic cell death, and that cells
resist early oxidative damage, suggesting that some key
intrinsic compensatory responses protect neurons from
the initial oxidative insult. Therefore, we speculated that
the persistently active catalytic fragment of PKCδ might
have other functions during the early stages of oxidative
stress, and so we further explored downstream signaling
mechanisms.
Protein kinase D1 (PKD1) is a calcium/calmodulin-
dependent member of the CAMK kinase family and can
be activated by dual phosphorylation of seine residues
(Ser 744/748) in the catalytic domain by different PKCs,
depending upon the cellular type and stimuli [22-24].
PKD1 is activated in response to multiple stimuli
including growth factors, phorbol esters, G-protein
coupled receptors, genotoxic stress and oxidative stress
[25-28]. In non-neuronal cells, PKD1 activation has
been shown to play a role in diverse cellular functions
including proliferation, cytoskeletal reorganization, golgi
function and immune response [27,29-32]. PKD1 has
been shown to regulate various cell signaling molecules
and pathways including ERK1/2, JNK pathways [33-35],
effector enzymes like MnSOD that scavenge ROS
[31,36], transcriptional regulators including NF-Ba n d
MEF2 [37,38], stress responsive chaperones like HSP27
[39], and some members of the HDAC family [26,31,40].
Recently, PKD1 was recognized as an important mito-
chondrial ROS sensor that translocates to the nucleus to
switch on cell survival mechanisms [36]. Also, PKD1
activation loop phosphorylation has been shown as an
early marker of sympathetic neuronal DNA damage
[41]. In neuronal models, PKD1 regulates trafficking of
dendritic membrane proteins to maintain neuronal
polarity and synaptic plasticity [42].
While many biological functions of PKD1 are beginning
to emerge, the role of PKD1 in the brain, specifically in
the nigral dopaminergic system, remains unknown. The
relationship between PKD1 signaling and neurodegenera-
tion has not yet been examined in a single study. Herein,
we demonstrate that PKD1 closely interacts with PKCδ
and serves as a key compensatory protective mechanism
in dopaminergic neuronal cells during the early stages of
oxidative insult.
Results
Role of PKCδ cleavage in the early stages of H2O2-
induced oxidative stress in dopaminergic neuronal cells
H2O2 is a common oxidative insult used to probe var-
ious cellular signaling pathways in different cell types
including neuronal cells [15,43,44]. We have already
demonstrated that H2O2 causes dose- and time-depen-
dent cytotoxicity, DNA fragmentation and cell death in
the dopaminergic neuronal N27 cell model [15]. In
order to determine the interrelationship between PKCδ
proteolytic cleavage and oxidative stress-induced cell
death, we examined the time course of PKCδ proteolytic
activation and cell death. As shown in Figure 1A, gen-
eration of ROS occurs as early as 1 h after H2O2 treat-
ment. Cytotoxicity begins between 90 and 120 min
(Figure 1B). PKCδ proteolytic cleavage and the kinase
activity increases during the early stage of H2O2 expo-
sure at 60 min (Figure 1C, D). Comparison of PKCδ
proteolytic activation and cytotoxicity at 60 min revealed
that PKCδ proteolytic activation occurs during the early
stages of oxidative stress preceding cell death (Figure
1E). There was no cell death during this intermediate
period between ROS generation and PKCδ proteolytic
activation. PKCδ knockdown by RNAi almost comple-
tely blocked the cell death induced by H2O2 at 120 min
of treatment, demonstrating the pro-apoptotic function
performed by PKCδ in N27 cells (Figure 1F). Impor-
tantly, a significant lag period between induction of cell
death and PKCδ proteolytic activation was observed.
This interesting observation prompted a search for cell
signaling mechanisms associated with a compensatory
protective response involving PKCδ proteolytic activa-
tion during early stages of oxidative stress.
Oxidative stress induces phosphorylation and activation
of PKD1 in a time-dependent manner
We hypothesized that the proteolytically cleaved PKCδ
might activate other downstream cell survival signaling
molecules to counteract the early stage of oxidative
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Page 2 of 18Figure 1 Relationship between PKCδ proteolytic activation and cell death during initial stages of H2O2 -induced oxidative stress in
N27 dopaminergic neuronal cell model. N27 dopaminergic cells were treated with H2O2 (100 μM) for 0-180 min and assayed for ROS
generation using DCFDA dye (A) and for cytotoxicity using Sytox green dye (B). Non-linear regression graph from two or more independent
experiments (n = 6-8). PKCδ cleavage was monitored by Western blot in a time dependent manner for 0 - 90 min in N27 dopaminergic cells
treated with H2O2 (100 μM) (C). N27 dopaminergic cells were treated with H2O2 (100 μM) for 0, 30 or 60 minutes and PKCδ kinase activity was
measured using [
32P] kinase assay; the bands were quantified for the graph (D). Data quantified from B and C were used to generate a bar
graph and were compared with cytotoxicity and PKCδ cleavage following H2O2 exposure for 60 min. **, p < 0.01 as indicated by two-way
ANOVA analysis using Bonferroni post test (E). N27 cells were transfected with 1 μM PKCδ siRNA and non-specific siRNA for 24 h and treated
with 100 μMH 2O2 and monitored for cytotoxicity using Sytox green dye, which showed significant protection from oxidative stress. ***, p <
0.001 denotes significant difference between non-specific siRNA- H2O2 and PKCδ siRNA H2O2-treated groups from two or more independent
experiments (n = 6-8). Statistics were performed by one-way ANOVA analysis using Bonferroni post test (F).
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matic approach to search for a key pro-survival mole-
cule that interacts with PKCδ. Scansite Motif Scanner
software [45] predicted that out of all the PKCs, only
PKCδ can phosphorylate the protein kinase D1 (PKD1)
activation loop ser residue at high stringency search
(additional file 1). Further literature review indicated
that PKD1 is an oxidative stress-responsive kinase that
can be activated by phosphorylation at the activation
loop (S744/S748) in non-neuronal models [22-25,46].
This encouraged us to look further for the expression
and activation of PKD1 in dopaminergic neuronal cells.
Immunocytochemical staining showed abundant
expression of PKD1 in N27 dopaminergic cells, as visua-
lized by confocal and fluorescence microscopy (Figure
2A), which is similar to the expression pattern of PKCδ
in this cell type. Importantly, PKD1 is also highly
expressed in primary tyrosine hydroxylase (TH) positive
dopaminergic neurons obtained from mouse substantia
nigra in the cytosolic region (Figure 2B).
To determine if oxidative stress can induce PKD1 Ser
744/Ser 748 phosphorylation in the activation loop, we
examined the ability of H2O2 to induce time-dependent
PKD1 activation loop phosphorylation in N27 dopami-
nergic cells. As shown in Figure 2C, 100 μMH 2O2
induced transient PKD1 activation loop phosphorylation
Figure 2 PKD1 is highly expressed in dopaminergic neurons and activated during initial stages of H2O2 -induced oxidative stress.
Immunofluorescence analysis of N27 dopaminergic cells stained for native PKD1 using fluorescence and confocal microscopy. Nuclei were
stained with Hoechst dye (A). Primary dopaminergic neurons staining for tyrosine hydroxylase (TH) obtained from the mouse substantia nigral
region show co-localization of native PKD1 with TH. TH - Green, PKD1 native - Red, Nucleus - Blue, Yellow -Merge. Nuclei were stained with
Hoechst dye (B). N27 dopaminergic neuronal cells were treated with or without H2O2 (100 μM) for 30, 60 or 90 min and probed for PKD1
activation loop phosphorylation pS744/pS748 and native PKD1 expression (C). N27 cells were treated with or without H2O2 (100 μM) and PKD1
kinase activity was measured by [
32P] kinase assay using syntide 2 substrate at 60 min (D). *, p < 0.05 denotes significant difference between
untreated and H2O2 -treated groups.
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30 min, peaking at 60 min and returning to control
levels after 90 min, with native protein levels remaining
the same. We also observed a second band around 100
kDa, which might correspond to the other isoform,
PKD2. According to the manufacturers (Cell Signaling
T e c h n o l o g y ) ,t h ep h o s p h o - s p e c i f i ca n t i b o d yc a na l s o
detect PKD2 Ser 706/Ser 710 phosphorylation because
of the conserved activation loop residues between PKD
isoforms. However, the PKD2 activation loop phosphor-
ylation does not follow the transient pattern of activa-
tion observed with PKD1 (Figure 2C). Furthermore, the
activation loop phosphorylation of PKD1 increased the
PKD1 kinase activity, as measured by a [
32P] kinase
assay using Syntide 2 substrate (Figure 2D). Collectively,
these results demonstrate that oxidative stress activates
PKD1 at early stages through phosphorylation of the
dual phospho sites pS744/pS748.
Oxidative stress-induced PKD1 activation
depends on PKCδ
To further determine whether PKCδ regulates PKD1,
we used both pharmacological and genetic approaches
to suppress the PKCδ and then measured the level of
PKD1 activation. Treatment of N27 cells with the PKCδ
inhibitor rottlerin (1 μM) completely suppressed H2O2
-induced PKD1 activation (Figure 3A), suggesting a
potential role of PKCδ in PKD1 activation. Next, we
used the PKCδ-specific siRNA to knockdown PKCδ and
then probed for PKCδ expression and PKD1 phosphor-
ylation. PKCδ knockdown completely attenuated PKD1
activation loop phosphorylation except for the bottom
band, corresponding to 100 kDa PKD2 (Figure 3B).
Furthermore, PKD1 activity was measured by [
32P]
kinase assay in PKCδ knockdown samples. The suppres-
sion in PKCδ expression completely attenuated PKD1
activation during H2O2 -mediated oxidative stress, con-
firming that PKCδ is indeed involved in PKD1 activa-
tion (Figure 3C). To show the specificity of PKCδ in
PKD1 activation in neuronal models, we used PKCa
siRNA and then measured PKD1 activation loop phos-
phorylation (additional file 2). Knockdown of PKCa did
not attenuate PKD1 activation loop phosphorylation,
further demonstrating the specificity of PKCδ-mediated
PKD1 phosphorylation in dopaminergic neuronal
models.
The constitutively active catalytic fragment of PKCδ
mediates PKD1 activation
Time course analysis of PKCδ proteolytic cleavage and
PKD1 activation revealed that the onset of proteolytic
activation of PKCδ coincides with the maximal activation
of PKD1 at 60 min following H2O2-induced oxidative
stress (Figure 4A). Previously, we had shown that caspase-
3 inhibitor z-DEVD-fmk and pan caspase inhibitor
ZVAD-fmk attenuate H2O2-induced proteolytic activation
of PKCδ. Therefore, we examined whether the proteolyti-
cally activated PKCδ contributes to PKD1 activation. As
shown in Figure 4B, co-treatment with z-DEVD-fmk and
ZVAD-fmk for 1 h significantly blocked H2O2-induced
activation loop phosphorylation of PKD1 as well as pro-
teolytic cleavage of PKCδ. Coincidentally, H2O2-induced
activation loop phosphorylation of PKD2 was not affected
in the presence of these caspase inhibitors. To further con-
firm the role of proteolytically activated PKCδ in PKD1
activation, we used N27 cells stably expressing the PKCδ
cleavage-resistant mutant PKCδ
D327A (PKCδ-CRM). H2O2
treatment in PKCδ-CRM cells significantly attenuated
PKD1 phosphorylation, confirming that the proteolytically
cleaved PKCδ contributes to PKD1 phosphorylation dur-
ing early stages of oxidative stress (Figure 4C). To further
support this observation, we separately over-expressed
the PKCδ catalytic fragment (V5-PKCδ-CF) and PKCδ
regulatory fragment (V5-PKCδ-RF) using a lentiviral vec-
tor (plenti6/V5-D-TOPO) in N27 cells and then evaluated
for activation of PKD1. Interestingly, V5-PKCδ-CF over-
expressing cells had increased PKD1 phosphorylation,
while V5-PKCδ-RF over-expressing cells did not increase
phospho-PKD1 levels (Figure 4D). Collectively, these
results demonstrate that the constitutively active catalytic
fragment of PKCδ mediates PKD1 activation loop
phosphorylation.
PKD1 activation functions as an anti-apoptotic protective
mechanism against oxidative stress
We previously reported that proteolytically activated
PKCδ (PKCδ-CF) mediates apoptosis in neurotoxicity
models [15,19,47] and therefore, we initially hypothe-
s i z e dt h a tP K C δ proteolytic cleavage-dependent activa-
tion of PKD1 may have a proapoptotic function.
Surprisingly, PKD1 knockdown siRNA significantly
augmented H2O2 -induced cell death at 2 h, as mea-
sured by Sytox cell death assay (Figure 5A). PKD1
knockdown increased cell death by nearly twofold
compared to control groups during H2O2 treatment,
indicating a pro-survival role for PKD1 against oxida-
tive stress (Figure 5B). Visualization of PKD1 knock-
down cells by phase contrast and fluorescence
microscopy further confirmed that PKD1 knockdown
cells are more sensitive than non-specific control cells
to H2O2-induced cytotoxicity (Figure 5C and 5D). We
further measured the H2O2 -induced apoptosis in
PKD1 knockdown cells by DNA fragmentation ELISA
assay at 3 h. The results showed an increase in DNA
fragmentation in the PKD1 knockdown group, as com-
pared to the non-specific siRNA control group, further
confirming the anti-apoptotic role of PKD1 in dopami-
nergic cells (Figure 5E).
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Page 5 of 18Figure 3 PKCδ dependent phosphorylation of PKD1 activation loop. N27 dopaminergic cells were treated with H2O2 (100 μM) with or
without 1 μM rottlerin, and the lysates were probed for PKD1 activation phosphorylation (A). N27 dopaminergic cells were transfected with 1
μM PKCδ siRNA and non-specific siRNA and monitored for PKCδ protein expression and PKD1 activation loop phosphorylation after H2O2
treatment (B) and PKD1 kinase activity assay was performed. **, p < 0.01 denotes significant difference between NS-siRNA-H2O2 and PKCδ-siRNA-
H2O2 groups (C).
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Page 6 of 18PKD1 C-terminal Ser 916 phosphorylation precedes PKD1
Ser 744/Ser 748 activation loop phosphorylation during
oxidative stress
We also characterized the sequential mechanisms of PKD1
activation in dopaminergic neuronal cells. We investigated
the other two key phosphorylation sites of PKD1, Tyr 469
and Ser 916. As shown in Figure 6A H2O2-induces transi-
ent phosphorylation of PKD1 Ser 916 in a time-dependent
manner. The data suggests that PKD1 C-terminal Ser 916
was rapidly phosphorylated as early as 10 min after H2O2
treatment continues to increase up to 90 min and
decreases at 150 min (Figure 6A). The phospho PKD1-
Figure 4 Proteolytically activated PKCδ-CF contributes to PKD1 phosphorylation. N27 dopaminergic cells treated with H2O2 (100 μM) for
30, 60 or 90 minutes were monitored for PKCδ-CF (A). N27 dopaminergic cells were treated with H2O2 ± DEVD-fmk (50 μM) and ± ZVAD-fmk
(50 μM and 100 μM) for 60 min and monitored for PKD1 activation and PKCδ cleavage (B). N27 dopaminergic cells stably expressing the
cleavage-resistant mutant of PKCδ (PKCδ
D327A) were treated with H2O2 and monitored for PKD1 activation (C). PKD1 activation was monitored in
N27 dopaminergic cells transfected with the catalytic fragment of PKCδ (PKCδ-CF) and the regulatory fragment of PKCδ (PKCδ-RF). Additionally,
the mock transfection group treated with or without H2O2 was also monitored for PKD1 activation (D).
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Page 7 of 18Figure 5 PKD1 has a cell survival function during oxidative stress in dopaminergic neuronal cells. N27 dopaminergic cells were transfected
with 1 μM PKD1 siRNA and non-specific siRNA (A) and treated with 100 μMH 2O2 for 120 minutes and monitored for cytotoxicity using Sytox green dye.
Fluorescence measurements for the incorporation of Sytox green read using a flourescence plate reader (B) and visualised by phase contrast and
fluorescence microscopy (C&D). DNA fragmentation assay (E) showed increased cytotoxicity and apoptosis in PKD1 knocked down samples exposed to
H2O2. *, p < 0.05 and ***, p < 0.001 denote significant difference between Non-Specific siRNA- H2O2 and PKD1 siRNA-H2O2 treated groups.
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other hand, H2O2 failed to induce PKD1-tyr 469 phos-
phorylation in N27 dopaminergic cells (Figure 6A). Our
results are consistent with a previous study suggesting that
PKD1 tyr 469 phosphorylation does not occur in H2O2-
treated Swiss 3T3 cells [48]. Similarly, it was shown that
Vasopressin a GPCR agonist can activates PKD1 in Swiss
3T3 cells [30]. Since H2O2 did not phosphorylate tyr 469,
we used desmopressin, a synthetic analogue of vasopressin
to induce tyr 469 phosphorylation. Exposure of N27 dopa-
minergic cells to the positive control desmopressin
induced tyr 469 phosphorylation (Figure 6B). To further
evaluate the involvement of PKD1 Ser 916 phosphoryla-
tion in PKD1 activation, we overexpressed the PKD1
S916A
mutant and PKD1
WT plasmids in dopaminergic cells and
then stimulated the cells with H2O2. Overexpression of
PKD1
S916A mutant blocked PKD1 activation loop phos-
phorylation (Figure 6C), suggesting that Ser 916 phosphor-
ylation is an early event that has to occur prior to PKD1
activation loop phosphorylation. Furthermore, knockdown
of PKCδ attenuated PKD1
S916 phosphorylation, demon-
strating that this is PKCδ dependent (Figure 6D).
Together, these results suggest that PKD1 Ser 744/Ser 748
activation loop phosphorylation is intrinsically regulated
by PKCδ via C-terminal phosphorylation of PKD1 Ser916.
PKD1 activation acts as a protective compensatory
mechanism during early stages of oxidative stress
To understand the relationship between PKCδ/PKD1
activation and neuronal cell death during oxidative
stress, we quantified the PKCδ/PKD1 activation profile
from the Western blots and then compared them with
the profile of neuronal cell death during H2O2-induced
oxidative stress. As shown in Figure 7A, PKD1 was acti-
vated at the early stages of oxidative insult and no mea-
surable cell death was observed until PKD1 activation
started declining to basal levels. Alternatively, PKCδ
activation was concomitantly increased along with H2O2
-induced cytotoxic cell death at the later stage of oxida-
tive stress. Thus, the inverse correlation of PKD1 activa-
tion with cytotoxicity suggests that PKD1 activation may
act as a compensatory protective response during early
stages of oxidative insult. To test this hypothesis, we
first overexpressed the full-length human PKD1
(PKD1
WT)i nN 2 7c e l l sa n dt h e ne x a m i n e dt h eH 2O2
-induced cytotoxicity. As anticipated, PKD1
WT overex-
pression protected the dopaminergic cells against oxida-
tive stress-induced cytotoxicity at 2 h (Figure 7B). In
order to establish the pro-survival function of PKD1
activation, we examined whether overexpression of the
PKD1
S916A phosphorylation defective mutant exacer-
bated H2O2 -induced neuronal cell death. As shown in
Figure 6 PKCδ-dependent phosphorylation of PKD1 at S916
site precedes PKD1 S744/S748 active loop phosphorylation.
N27 dopaminergic cells were treated with 100 μMH 2O2 for 10-90
min and monitored for PKD1Y469, PKD1 S916 and PKD1 S744/S748
phosphorylation (A). N27 dopaminergic cells were treated with or
without 50 nM desmopressin for 1 h and monitored for PKD1 Y469
phosphorylation. The cells show PKD1 Y469 phosphorylation when
exposed to desmopressin, while carbachol does not cause PKD1
Y469 phosphorylation (B). N27 cells expressing PKD1
S916A mutant
blocked PKD1 activation during oxidative stress, as seen by Western
blotting for PKD1 S744/S748 phosphorylation and HA expression (C).
N27 dopaminergic cells were transfected with 1 μM PKCδ siRNA
and non-specific siRNA and monitored for PKCδ protein expression
and PKD1 S916 phosphorylation after treatment with or without
H2O2 (D).
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S916A phosphory-
lation defective mutant exacerbated H2O2 -induced
cytotoxic cell death as early as 90 minutes, compared to
vector overexpressing cells. To further confirm our
hypothesis that PKD1 activation loop phosphorylation
acts as an early protective compensatory response, we
overexpressed the activation loop active plasmid
(PKD1
S744E/
S748E), where the replacement of serine with
glutamate makes the kinase constitutively active [49],
and cytotoxicity was monitored for up to 3h following
H2O2 treatment (Figure 7D). The constitutively active
PKD1 mutants tremendously suppressed the cytotoxi-
city, even during late stages of oxidative insult, indicat-
ing that PKD1 activation is a very significant early
protective compensatory mechanism in dopaminergic
cells. Collectively, these results demonstrate that PKD1
Figure 7 PKD1 activation acts as an early protective compensatory mechanism. A comparative time course graph based on quantifying
PKD1 activation profile, PKCδ cleavage profile and cytotoxicity during H2O2 exposure (A). N27 dopaminergic cells transiently transfected with 5
μM full length PKD1 plasmid (PKD1
WT) and 5 μM vector plasmid were treated with or without 100 μMH 2O2 for 150 minutes and monitored for
cytotoxicity using sytox green; PKD1 protected against cytotoxicity (B). N27 dopaminergic cells transiently transfected with 5 μM PKD1
S916A
plasmid and 5 μM vector plasmid were treated with or without 100 μMH 2O2 for 150 minutes and monitored for cytotoxicity using sytox green;
increased cytotoxicity was observed in the cells (C). N27 dopaminergic cells transiently transfected with 5 μM PKD1
S744E/S748E and 5 μM vector
plasmid (D) were treated with or without 100 μMH 2O2 and monitored for cytotoxicity at various time points using sytox green. ***, p < 0.001
denotes significant difference between treatment groups from n≥6.
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stages of oxidative stress to protect against cytotoxicity
in dopaminergic cell models.
Activated PKD1 translocates to nucleus during oxidative
stress in cell culture models of neurodegeneration
We also performed immunocytochemical staining to
examine the subcellular localization of activated PKD1
during oxidative stress. Activated PKD1 (PKD1pS744/
pS748) (green) co-localized with the nuclear Hoechst
stain (blue) at 1 h during H2O2 -induced oxidative stress
in N27 cells, as visualized by fluorescence microscopy
(Figure 8A). These results indicate that activated PKD1
translocates to the nucleus of dopaminergic neuronal
cells to carry out cell repair and survival functions.
Furthermore, we examined oxidative stress-induced
PKD1 activation in primary mesencephalic dopaminergic
neurons. Mouse primary mesencephalic neuronal
Figure 8 Activated PKD1 translocates to nucleus during H2O2 -induced oxidative stress. Immunofluorescence analysis of N27
dopaminergic cells stained for activated PKD1 using fluorescence microscopy during H2O2 exposure show translocation to nucleus. PKD1pS744/
S748 - Green, Nucleus - Blue. Nuclei were stained with Hoechst dye (A). Immunofluorescence analysis of primary dopaminergic neurons staining
for TH obtained from the mouse substantia nigral region shows translocation of activated PKD1 to the nucleus during H2O2 exposure.TH-Green,
PKD1pS744/S748 - Red, Nucleus - Blue, Merge - Pink. Nuclei were stained with Hoechst dye (B). Primary dopaminergic neurons staining for TH
show presence of PKD1pS916 in both cytosol and nucleus during H2O2 exposure. TH - Green, PKD1pS916- Red, Nucleus - Blue, Pink - Merge in
nucleus, yellow -Merge in cytosol. Nuclei were stained with Hoechst dye (C).
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induce oxidative stress and then subcellular localization
of PKD1 activation was monitored by TH/PKD1 double
immunolabeling. Activated PKD1 (red) (PKD1 pS744/
pS748) co-localized (pink) with the nuclear Hoechst
stain (blue) following H2O2 treatment in primary
mesencephalic neurons staining for TH (green), as
visualized by fluorescence microscopy (Figure 8B). We
also examined the activation profile of PKD1 pS916 C-
terminal phosphorylation. PKD1pS916 (red) was loca-
lized (pink/yellow) in both cytosol and nucleus of TH
+ve primary mesencephalic neurons staining for green
during H2O2 -induced oxidative stress (Figure 8C).
Parkinsonian-specific toxicant causes PKD1 activation
Activation of this signaling pathway was also tested
using the parkinsonian-specific toxicant 6-OHDA. We
treated N27 cells with 100 μM 6-OHDA and performed
a time-course analysis for 1, 3, and 6 h. PKD1 activation
started as early as 1 h and continued until 3 h before
reaching control levels at around 6 h (Figure 9). This
further confirmed the involvement of PKD1 signaling
during parkinsonian-specific oxidative insult.
Discussion
The present study reveals a novel protective compensa-
tory signaling mechanism via PKCδ-PKD1 molecular
interaction in dopaminergic neuronal cells. Through our
collective results, we report for the first time four key
findings in a dopaminergic neuronal model pertinent to
oxidative stress-mediated neurodegenerative processes:
(i) A proteolytically activated catalytic PKCδ fragment
(PKCδ-CF) phosphorylates and activates protein kinase
D1 (PKD1); (ii) PKD1 activation counteracts early stage
oxidative damage and protects dopaminergic neuronal
cells from cytotoxicity; (iii) PKCδ-dependent phosphory-
lation of ser 916 residue precedes ser 744/ser 748; (iv)
PKCδ - PKD1 crosstalk tightly regulates cell survival
and cell death to maintain cellular homeostasis in
response to oxidative damage. The elucidation of this
compensatory signal transduction mechanism in neuro-
degenerative diseases may enhance understanding of
degenerative processes and lead to development of novel
treatment modalities.
H2O2-induced cytotoxicity causes apoptosis in neuronal
and non-neuronal cells [15,43,44,50]. Generally, oxidative
stress-induced apoptosis can be classified into early and
late stages. DNA fragmentation occurs in the late stage
of apoptosis and is preceded by ROS generation,
mitochondrial dysfunction and caspase-3 activation and
membrane phosphatidyl exposure [10,47]. In neurodegen-
erative disorders, especially PD, the signaling mechanisms
that contribute to increased vulnerability of dopaminergic
neurons to oxidative damage are still under investigation.
Most current research focuses on cell death mechanisms
in dopaminergic neurons. Some of the signaling kinases
responsible for cell death mechanisms in PD include
JNK, MLK, MAPK, LRRK2, etc. [51-54]. Earlier, the
involvement of a novel biochemical mechanism for cell
death in dopaminergic neurons through caspase-mediated
proteolytic activation of PKCδ was demonstrated [15-19].
The high levels of persistently active PKCδ catalytic frag-
ment mediate apoptosis during oxidative stress in both
cell culture and animal models of PD [15-19]. We also
have shown in our earlier study that a positive feedback
loop exists during the late stages of oxidative stress,
where the persistently active PKCδ catalytic fragment
translocates to the mitochondria to promote cytochrome
C release and apoptosis [16,17,55].
We previously demonstrated proteolytic activation of
PKCδ occurs during the early stages of oxidative stress,
even before cell death can occur, and coincides with the
initiation of mitochondrial ROS generation/caspase-3
activation in dopaminergic neurons [15,17]. Thus, we
speculated that proteolytically activated PKCδ might
play a regulatory role during the early stages of apopto-
sis. Previous research suggests the presence of a variety
of protective compensatory mechanisms that counteract
the early oxidative insult [8-10]. Since we observed in
our present study a significant lag time before induction
of cell death during the early stages of oxidative stress
(Figure 1B), we hypothesize that proteolytically activated
PKCδ might sense the extent of oxidative damage and
act as a homeostatic regulator in response to oxidative
stress, modulating cell survival and cell death mechan-
isms through interactions with protective signaling
molecules.
Protein kinase D1 (PKD1) is emerging as an important
signaling molecule associated with oxidative stress in
non-neuronal cell lines [31,35,36]. Studies have shown
that oxidative stress increases PKD1 activation loop
Figure 9 PKD1 is activated by 6-OHDA induced oxidative
stress. N27 dopaminergic neuronal cells were treated with or
without 6-OHDA (100 μM) for 1, 3, and 6 h and probed for PKD1
activation loop phosphorylation pS744/pS748 and PKCδ cleavage.
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including PKCδ, in non-neuronal models [37,56-59].
However, the functions of PKD1 during oxidative stress-
induced neurodegeneration have not been studied pre-
viously. In the present study, we report that cleaved
active PKCδ phosphorylates the activation loop of PKD1
and activates the kinase during the early stages of H2O2
-induced oxidative stress in dopaminergic neuronal cells.
We also observed a similar activation pattern for PKD1
and PKCδ during oxidative stress caused by the parkin-
sonian-specific toxicant6 - O H D A( F i g u r e9 ) .T oo u r
knowledge, this is the first report of a novel cell survi-
val/cell death signal regulation by the cleaved catalytic
fragment of PKCδ at two different stages of apoptosis
based on the extent of oxidative damage.
PKD1 is mainly activated by a diacylglycerol-depen-
dent PKCs mechanism [22,60] or by PKD1 cleavage
[61-63]. A recent study shows that PKD1 auto-inhibi-
tion is released through phosphorylation at the Y463
site in the regulatory domain, leading to the activation
loop phosphorylation by PKCδ full length (PKCδ-FL)
in Hela cells [24]. PKD1 is in a closed conformation
during the resting stage, with the regulatory fragment
having an autoinhibitory effect on the catalytic frag-
ment [46,64]. Multiple phosphorylation sites on PKD1
seem to be important for its activation loop phosphor-
ylation, depending on the cell types and stimuli. In
human cancer cell lines, PKD1 can be phosphorylated
at multiple sites including Y463, S910 (corresponding
to murine Y469, S916) [24,65]. Phosphorylation of Ser
916 (murine) autophosphorylation site correlated with
PKD1 activation loop phosphorylation [58,66]. During
oxidative stress in non-neuronal models, Tyr 469 is
phosphorylated by upstream kinases, which results in
release of the Pleckstrin homology (PH) domain auto-
inhibition prior to activation loop phosphorylation; this
mechanism does not involve C-terminus Ser 916 phos-
phorylation [24,37]. In our dopaminergic neuronal
models, oxidative stress failed to induce PKD1 Tyr 469
phosphorylation (Figure 6A), whereas PKD1 Tyr 469
phosphorylation was induced by the positive control
desmopressin (Figure 6B). Our results demonstrate
that the mechanism of PKD1 activation in dopaminer-
gic neurons is distinct from the mechanisms in other
non-neuronal models. We demonstrate that S916
phosphorylation, but not Tyr 469 phosphorylation, is a
preceding event that occurs and is required for
PKD1ser744/Ser748 activation loop phosphorylation
(Figure 6). Our data suggest that Ser 916 phosphoryla-
tion on the C-terminal of PKD1 may open the confor-
mation for full activation of the kinase through
activation loop phosphorylation during oxidative stress
in dopaminergic neurons. A detailed comparative ana-
lysis of PKCδ proteolytic activation, PKD1 activation
loop phosphorylation and the extent of cell death dur-
ing oxidative stress revealed an interesting functional
relationship between activation of kinases and regula-
tion of cell death. Comparison of PKD1 activation and
cytotoxicity shows that PKD1 activation is maximal
during the early oxidative stress stage when no mea-
surable cytotoxicity is noted (Figure 7A). Interestingly,
when PKD1 activation begins to decline at the end of
the early stage, cell death begins to occur. Also, the
level of PKCδ proteolytic activation directly correlates
with the extent of cell death at the later stage of oxida-
tive stress. When the constitutively active PKD1
mutant (PKD1
S744E/
S748E) is overexpressed, dopaminer-
gic cells are resistant to H2O2 -induced neurotoxicity,
even during the late stages of oxidative stress (Figure
7D), which is consistent with our hypothesis that
PKD1 activation protects against oxidative damage.
The downstream signaling mechanisms of PKD1 acti-
vation in dopaminergic neuronal cells are not known.
PKD1 translocates to the nucleus and regulates phos-
phorylation of HDACs and various transcription fac-
tors in various non-neuronal cell lines including B cell,
cardiomyocytes & oestoblasts [31,23,40,67]. PKD1
translocation to the nucleus after activation in dopami-
nergic neurons is also noted in the present study (Fig-
ure 8), suggesting that nuclear translocation of PKD1
may activate key cell survival transcription factors and
genes. Thus, we suggest that PKD1 functions as a cell
survival switch and turns ‘ON’ a protective compensa-
tory mechanism in dopaminergic neurons. Studies are
underway to characterize the downstream protective
response of PKD1 signaling in nigral dopaminergic
neurons.
Conclusions
Our results demonstrate that the PKD1-mediated pro-
tective mechanism is a novel signal transduction path-
way that regulates cell survival and cell death during
various stages of oxidative stress in dopaminergic neuro-
nal cells. As depicted in Figure 10, in the early stages of
oxidative insult, PKCδ acts as an oxidative stress sensor/
regulator and activates PKD1, which serves as a key
compensatory protective mechanism against oxidative
damage. However, prolonged oxidative insult creates a
homeostatic imbalance, causing deactivation of PKD1
and persistent proteolytic activation of PKCδ that con-
tribute to extensive neuronal damage. We previously
showed a parallel proapoptotic mechanism involving
translocation of PKCδ catalytic fragments to the mito-
chondria, resulting in a persistent increase in caspase-3
dependent PKCδ proteolytic cleavage via a positive feed-
back loop mechanism [16,17,55]. Our results suggest
that positive modulation of the PKD1-mediated pro-
tective mechanism against oxidative damage in
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tive strategies for treatment of PD.
Materials and methods
Cell Culture
The immortalized rat mesencephalic dopaminergic neuro-
nal cell line (N27) was a kind gift from Dr. Kedar N. Pra-
sad (University of Colorado Health Sciences Center,
Denver, CO). N27 cells were grown in RPMI 1640 med-
ium containing 10% fetal bovine serum, 2 mm l-glutamine,
50 units of penicillin, and 50 μg/ml streptomycin. Cells
were maintained in a humidified atmosphere of 5% CO2
at 37°C, as described previously [16]. N27 cells are used
widely as a cell culture model for PD [20,15,21,16,68].
Primary mesencephalic neuronal culture
Primary mesencephalic neuronal cultures were prepared
from the ventral mesencephalon of gestational 16- to
18-day-old mouse embryos, as described earlier [69].
Tissues were dissected from E16 to E18 mouse embryos
maintained in ice cold Ca2+-free Hanks’ balanced salt
solution and then dissociated in Hanks’ balanced salt
solution containing trypsin-0.25% EDTA for 30 min at
37°C. The dissociated cells were then plated at equal
density (0.5 × 106 cells) on 12 mm coverslips precoated
with 0.1 mg/ml poly-D-lysine. Cultures were maintained
in neurobasal medium fortified with B-27 supplements,
500 μM l-glutamine, 100 IU/ml penicillin, and 100 μg/
ml streptomycin (Invitrogen). The cells were maintained
in a humidified CO2 incubator (5% CO2 and 37°C).
Half of the culture medium was replaced every 2 days.
Approximately 6- to 7-day-old cultures were used for
experiments. Primary mesencephalic dopaminergic neu-
ronal cells were exposed to 10 μM for 1 h.
Treatment Paradigm
N27 cells were exposed to H2O2 (100 μm) for 0-4 h at
37°C. Primary neurons were exposed to H2O2 (10 μm)
for 1 h. Cell lysates were used for Western blotting and
immunoprecipitation studies. Untreated cells were
grown in the complete medium and used as the experi-
mental control.
Cytotoxicity Assays
Cell death was determined using the Sytox green cyto-
toxicity assay, after exposing the N27 cells to H2O2 (100
μm), as described previously. This cytotoxicity assay was
optimized for a multiwell format, which is more efficient
and sensitive than other cytotoxicity measurements
[70,71]. Briefly, N27 cells were grown in 24-well cell cul-
ture plates at 100,000 cells per well and treated with
H2O2 (100 μm) and 1 μm Sytox green fluorescent dye.
The Sytox green assay allows dead cells to be viewed
directly under a fluorescence microscope, as well as
quantitatively measured with af l u o r e s c e n c em i c r o p l a t e
reader (excitation 485 nm; emission 538 nm) (Biotek).
Phase contrast and fluorescent images were taken after
H2O2 exposure with a NIKON TE2000 microscope, and
pictures were captured with a SPOT digital camera.
ROS Generation Assay
ROS generation was monitored by CM-DCFDA dye, as
described previously [15,72].T h i si san o n - f l u o r e s c e n t
dye in its reduced form, but after oxidation in the cells,
the acetate group is removed by cellular esterases, result-
ing in fluorescence. N27 cells were seeded in 48-well
plates at a confluence of 40,000 cells/well for 24 h. First,
cells were loaded with 10 μM CM-DCFDA dye (Invitro-
gen) at 37°C for 1 h in the dark. Cells were then treated
with H2O2 in Hanks’ balanced salt solution (HBSS) and
the fluorescence of the cells was measured using the
synergy 2 fluorescence plate reader (Biotek) at various
time points (excitation 485 nm; emission 538 nm).
Figure 10 Schematic of PKCδ-PKD1 signal transduction
mechanism during oxidative stress in dopaminergic neuronal
cells. 1) Oxidative stress causes mitochondrial impairment; 2)
activation of caspase cascade; 3) caspase-3 mediates proteolytic
cleavage of PKCδ; 4) proteolytically cleaved PKCδ-catalytic fragment
(CF) is active; 5) PKCδ-CF activates PKD1 by activation loop
phosphorylation during the early stage of oxidative stress; 6) Fully
active PKD1 regulates cell survival function in N27 dopaminergic cells.
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The primary mesencephalic neurons or N27 cells after
H2O2 treatment were fixed with 4% paraformaldehyde
and processed for immunocytochemical staining. First,
nonspecific sites were blocked with 2% bovine serum
albumin, 0.5% Triton and 0.05% Tween-20 in phosphate-
buffered saline (PBS) for 20 min. The cells then were
incubated with antibodies directed against TH, native
PKD1 and PKD1-pS744/S748 in PBS containing 1% BSA
at 4°C overnight, followed by incubation with Alexa 488
and Alexa 568 conjugated secondary antibodies in PBS
containing 1% BSA. Secondary antibody treatments were
followed by incubation with Hoechst 33342 dye for 5
min at room temperature to stain the nucleus. The cov-
erslips containing stained cells were washed with PBS,
mounted on slides, and viewed under a Nikon inverted
fluorescence microscope (model TE-2000U; Nikon,
Tokyo, Japan). Both fluorescence and confocal images
were captured with a SPOT digital camera (Diagnostic
Instruments, Inc., Sterling Heights, MI).
Western Blot Analysis
Cells were lysed in either modified RIPA buffer or M-
PER buffer (Thermo Scientific) for Western blot,
immunoprecipitation and kinase assays. Lysates con-
taining equal amounts of protein were loaded in each
lane and separated on 10-12% SDS-PAGE, as described
previously (Kaul et al., 2003). PKD1 polyclonal
(1:1000), PKCδ polyclonal (1: 1000), PKD1-pS744/S748
(1:1000), PKD1-pS916 (1:1000), PKD1-pY469 (1:1000),
-a n db-actin (1:10000) antibodies were used to blot
the membranes. IR dye-800 conjugated anti-rabbit
(1:5000) and Alexa Fluor 680 conjugated anti-mouse
(1:10000) were used for antibody detection with the
Odyssey IR Imaging system (LICOR), as previously
described.
PKCδ Kinase Assay
Immunoprecipitation and PKCδ kinase assay were
performed as described earlier [15]. After cell lysis,
cell were immunoprecipitated using a polyclonal
PKCδ rabbit antibody and protein A Sepharose, and
washed three times with PKCδ kinase buffer (40 mM
Tris (pH 7.4), 20 mM MgCl2,2 0μMA T P ,2 . 5m M
CaCl2). The reaction was started by adding 20 μlo f
buffer containing 0.4 mg histone and 5 μCi of [g-
32P]
ATP (4,500 Ci/mM). After incubation for 10 min at
30°C, SDS loading buffer (2X) was added to the sam-
ples to terminate the reaction. The reaction products
were separated on SDS-PAGE (12%), and the H1-
phosphorylated bands were detected using a phos-
phoimager (Fujifilm FLA-5100) and quantified with
MultiGauge V3.0 software.
Protein Kinase D1 Kinase Assay
The cells were exposed to H2O2 (100 μM) for 1 h and
cell lysates were immunoprecipitated, as previously
reported, with native PKD1 antibody (Santa Cruz). The
kinase reaction was carried out at room temperature for
20 min after adding 10 μl of kinase substrate mix (0.1
mM ATP + 10 μci [g-
32P] ATP + 2 ug Syntide 2 peptide
substrate in kinase buffer). Kinase buffer contains 20 mM
Tris pH 7.5, 10 mM MgCl2,a n d1m MD T T .T h es a m -
ples were centrifuged to terminate the kinase reaction,
and the supernatants containing the phosphorylated pep-
tide were applied as spots to P81 phosphocellulose
squares (Whatmann). The papers were washed four times
with 0.75% phosphoric acid and once with acetone and
dried, and activity was determined by liquid scintillation
counting. The samples were also loaded on a SDS-PAGE
and probed for native PKD1 to determine equal loading.
DNA Fragmentation Assay
DNA fragmentation was measured using the Cell Death
Detection ELISA Plus assay kit (Roche), for the detection
of early apoptotic death, as described previously [15,72].
After 100 μmH 2O2 treatment, the cells were spun down
a t2 0 0×gf o r5m i na n dw a s h e do n c ew i t hP B S .T h e n
cells were lysed with lysis buffer provided with the kit.
After lysis, the samples were spun down at 10,000 rpm
for 10 min to collect the supernatant that was used to
measure DNA fragmentation. The supernatants were
further dispensed into the microtiter plates coated with
streptavidin containing HRP-conjugated antibody cocktail
that can detect the nucleosomes. After 2 h incubation,
the HRP substrate provided in the kit was added. Mea-
surements were taken in a Synergy 2 multiwell plate
reader at 405 nm, with 490 nm as a reference reading.
Transient and Stable Transfections
cDNA encoding PKCδ catalytic fragment (PKCδ-CF),
PKCδ regulatory fragment (PKCδ-RF) and PKCδ cas-
pase-resistant mutant (PKCδ-CRM) (PKCδ
D327A) from
the pEGFPN1 vector were subcloned into the lentiviral
expression vector plenti6/V5-d-TOPO in our lab (herein
referred to as V5-PKCδ-CF, V5-PKCδ-RF, V5-PKCδ-
CRM) [15,73]. ViraPower Lentiviral Expression System
(Invitrogen) was used to establish stable transfections of
a caspase-resistant mutant of PKCδ
D327A [73]. Full-
length human PKD1 plasmid (PKD1-FL), PKD1 activa-
tion loop, active PKD1
S744E/S748E (PKD1-CA) and
PKD1
S916A mutants were obtained from Addgene, Inc.
[74,49,37]. Electroporation was carried out with an
Amaxa Nucleofector transfector instrument, as per the
manufacturer’s protocol. The transfected cells were then
transferred to T-75 flasks or 6-well plates as desired and
allowed to grow for a 24 h period before the treatment.
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PKCδ-siRNA was prepared by an in vitro transcription
method, as described previously [20]. PKCδ-siRNA effec-
tively suppressed > 80% of PKCδ protein expression levels
within 24 h post-transfection. Predesigned PKD1-siRNA
was purchased from IDT, Inc. PKD1-siRNA effectively sup-
pressed > 80% of PKD1 protein expression levels after 36 h
post-transfection. N27 cells (50-70% confluence) were
transfected with siRNA duplexes using an Amaxa Nucleo-
fector kit (Amaxa), as described in our previous study [20].
Statistical Analysis
Data analysis was performed using Prism 3.0 software
(GraphPad Software, San Diego, CA). Bonferroni’sm u l t i p l e
comparison testing was used to find the significant differ-
ences between treatment and control groups. Differences
with p < 0.05, p < 0.01, and p < 0.001 were considered sig-
nificantly different from n ≥ 6 from two or more indepen-
dent experiments, and are indicated in the figures.
Additional material
Additional file 1: Rat PKD1 amino acid sequence obtained from
Swiss-Prot database (ID: Q9WTQ1) was analyzed using Scansite
Motif software to identify the upstream PKCs that phosphorylate
the PKD1 activation loop serine residues. The analysis done at high
stringency shows that only PKCδ phosphorylates PKD1 at the activation
loop residue Serine 744 site.
Additional file 2: N27 cells were transfected with 1 μM PKCa siRNA
and non-specific siRNA and monitored for PKCa protein expression
and PKD1pS744/S748 after H2O2 treatment. PKCa knockdown did not
cause attenuation in PKD1 activation loop phosphorylation.
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